Find the full details for how to watch the F1 Australian GP as the 2026 F1 World Championship Season gets started. Race times & schedule here.

New M5 Pro and M5 Max chips powering the latest MacBook Pro models bring Apple's new Fusion Architecture with super cores for more power.

The Senate and House of Representatives have both put forth budgets to fund the state of Wyoming over the next two years, and as of Monday, they were ...

The Senate and House of Representatives have both put forth budgets to fund the state of Wyoming over the next two years, and ...

A team of physicists led by Jared Fuchs at the University of Alabama in Huntsville has produced a peer-reviewed warp drive solution that works within known physics, using only positive energy and ...

Brent Venables is on the hunt to fill another spot on his coaching staff, with DeMarco Murray set to head to the NFL. For the third time this offseason, Oklahoma coach Brent Venables will have to look ...

Jason Chun is a CNET writer covering a range of topics in tech, home, wellness, finance and streaming services. He is passionate about language and technology, and has been an avid writer/reader of ...

Free AI tools Goose and Qwen3-coder may replace a pricey Claude Code plan. Setup is straightforward but requires a powerful local machine. Early tests show promise, though issues remain with accuracy ...

Super Bowl Sunday has arrived, and if this year's showdown between the Seattle Seahawks and New England Patriots is even half as thrilling as the last time these franchises met on this stage, fans are ...

OpenAI just lobbed a grenade at vibe-coding startups like Cursor and Windsurf. The company behind ChatGPT has announced the Codex MacOS app, its take on an integrated development environment (IDE) ...

I'm a Fitness & Nutrition writer for CNET who enjoys reviewing the latest fitness gadgets, testing out activewear and sneakers, as well as debunking wellness/fitness myths. In my free time I enjoy ...

Amgen has terminated its rocatinlimab collaboration with Kyowa Kirin, walking away from the anti-OX40 antibody five years after paying $400 million for rights to the autoimmune disease drug candidate.